Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma.

Kawabata, Yasunari

Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma. [electronic resource] - Pancreas Aug 2015 - 937-44 p. digital

Publication Type: Journal Article

1536-4828

10.1097/MPA.0000000000000348 doi


Adult
Aged
Aged, 80 and over
Ampulla of Vater--enzymology
Biomarkers, Tumor--analysis
Carcinoma--enzymology
Chemotherapy, Adjuvant
Chi-Square Distribution
Common Bile Duct Neoplasms--enzymology
DNA-Binding Proteins--analysis
Dihydrouracil Dehydrogenase (NADP)--analysis
Disease Progression
Disease-Free Survival
Endonucleases--analysis
Equilibrative Nucleoside Transporter 1--analysis
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local
Pancreaticoduodenectomy--adverse effects
Patient Selection
Proportional Hazards Models
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome